biotechnology and risk assessment: entransfood...“golden rice” with additional β1carotene is an...
TRANSCRIPT
Biotechnology and Risk
Assessment: ENTRANSFOOD
Gijs A. Kleter
SELAMAT conference, August 25, 2004
Schedule
� Introduction
� Safety assessment of GM products
� The ENTRANSFOOD project
� Conclusions
Illustration: CNN
Introduction
The worldwide area of genetically modified (GM)
crops has rapidly increased
0
20
40
60
80
1996 1997 1998 1999 2000 2001 2002 2003
yearm
illi
on
s o
f h
ec
tare
s
USA 63%
Argentina 21%
Canada 6%
Brazil 4%
China 4%
South Africa 1%
Segment 7
Total area, 199612003
Nations, 2003
Data source: C. James, ISAAA , 2003
Introduction
Examples of GM crops are herbicide1resistant
soybean and insect1resistant maize
Soybean
before afterherbicide1application
Maize
Introduction
“Golden rice” with additional β1carotene is an
example of a future biotech crop
Safety assessment of GM products
Illustration: CNN
GM crop
Additional
testing
Safety- and nutritional testing
Evaluation of data
Sufficient Not sufficient
Risk assessment
(New)
proteins
Introduced
genes
(New)
chemical
substances
Comparative safety assessment
� Substantial equivalence
� Toxicity
� Allergenicity
� Gene transfer
� Unintended effects
� Nutritional value
� Pesticide residues
Safety assessment of GM products
Profiling by LC1NMR
metabolites
GM crop
conventional
crop
extract metabolites
extract
extract
metabolites
generate NMR profiles
Safety assessment of GM products
Profiling by LC1NMRgenerate NMR profiles
identify differences
trace back to metabolite
Safety assessment of GM products
Illustration: CNN
The ENTRANSFOOD project
NEW SAFETY
TESTING
DETECTION OF
UNINTENDED
EFFECTS
CONSUMERS
CONFIDENCE
DETECTION,
TRACEABILITY
AND QUALITY
ASSURANCE
TRANSPARENCY
OF PROCEDURES
GENE TRANSFER
IMPROVED
GUIDELINES FOR
TESTING
HARMONISATION OF
RISK ASSESMENT
STRATEGIES
EUROPEAN NETWORK
SAFETY ASSESSMENT OF
GENETICALLY MODIFIED
FOOD CROPS
‘ENTRANSFOOD’
Illustration:
ESA
The ENTRANSFOOD project
Participating projects
� SAFOTEST
� Innovative safety testing of GMOs
� GMOCARE
� Detection of unintended effects
� GMOBILITY
� Gene transfer
� QPCRGMOFOOD and GMOCHIPS
� GMO detection and traceability
The ENTRANSFOOD project
� Coordination
� Dr. H.A. Kuiper
� Project participation
� 65 participants
� 13 countries
� Total budget
� >10,000,000 Euros
Illustration:
EU
The ENTRANSFOOD project
Working Groups
� Safety testing of transgenic foods
� Detection of unintended effects
� Gene transfer
� Traceability and quality assurance
� Societal aspects
The ENTRANSFOOD project
Activities
� Duration 200012003
� Meetings� Integrated Discussion Platform
� Plenary, Working Groups
� Management
� Exchange between projects� Training
� Website: www.entransfood.com
� Publications� Working Group papers, Food Chem. Toxicol.
� Overarching report
� Flyer(s)
The ENTRANSFOOD project
Outcomes
� Publications, presentations
� Recommendations from WGs
� Integration of research disciplines
� Example for current EU projects
� Intend to continue integrated platform
� Partially continued in EU1funded projects (FP6)
� SAFE FOODS
� NOFORISK
The ENTRANSFOOD project
Examples of recommendations� Combination of targeted and non1targeted analysis for safety assessment of GM crops (WG2)
� More efficient detection methods for GM materials against background of their numbers increasing (WG4)
� Research needed on optimalization of public consultation and engagement, as well as on its impact on risk analysis and government institutions (WG5)
The ENTRANSFOOD project
Examples of recommendations:
Integrated risk assessment approach (WG1)
SAFETY ASSESSMENT
EXPOSURE ASSESSMENT
2 TRANSFORMATION
History of Gene Insert
3 GENE PRODUCT
-Characterisation
-Mode of action
-Toxicity
-Allergenicity
-Other
Toxicology/Allergy
CONCLUSION ON SAFETY
RISK CHARACTERISATION
HAZARD CHARACTERISATION
HAZARD IDENTIFICATION
1 PARENT CROP
History of Crop Use
Comparison
Toxicology/Nutrition
Allergy (gene transfer)
4 GM CROP/DERIVED FOOD
-Phenotype/agronomy
-Composition
-Nutrition
-Safety evaluation
The ENTRANSFOOD project
Antibiotics relevant for human therapy III (avoid)
A) Widely distributed
B) Defined areas of human/veterinary medicine
II (low effect)
A) Widely distributed
B) No or only limited therapeutic relevance
I (no effect)
CharacteristicsGroup
Example of WG3 recommendations: antibiotic
resistance gene classification
Conclusions
� The comparative safety assessment of GM products has worked well and may be further developed in future, for example with supplementary profiling techniques
� The ENTRANSFOOD project has brought together researchers from different disciplines, as well as stakeholders, and its experiences are an example for the current research approach in the EU Sixth Framework Programme for R&D
Illustration: CNN
Illustration:
ESA
Wageningen
RIKILT –Institute of Food Safety
Thank you
© Wageningen UR